케이엠손해사정

비상장계속사업자

KM Loss Adjusters Co.,Ltd.

김종성

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

케이엠손해사정

Business Reg. No. 1078650412 · CEO 김종성

I.Investment Overview

Target케이엠손해사정 (1078650412)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명케이엠손해사정
영문명KM Loss Adjusters Co.,Ltd.
대표자김종성
사업자등록번호1078650412
법인등록번호1101113016030
설립일2004.05.21

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW145.82021158.720222142023245.62024271.12025
영업이익100M KRW-5.92021-1.62022-1.22023-6.42024-3.32025
순이익100M KRW1.12021020220.520230.220240.52025
Item20252024202320222021
자산총계37.7억원37.9억원29.5억원22.6억원22억원
부채총계30.9억원31.5억원23.4억원17억원16.5억원
자본총계6.8억원6.3억원6.1억원5.6억원5.6억원
매출액271.1억원245.6억원214억원158.7억원145.8억원
영업이익-3.3억원-6.4억원-1.2억원-1.6억원-5.9억원
순이익5,375만원2,255만원4,895만원349만원1.1억원

VI.Financial Ratios

FY2025 basis

-1.21%

영업이익률

0.2%

순이익률

1.42%

ROA

7.85%

ROE

451.18%

부채비율

18.14%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

케이엠손해사정 투심보고서 | Alpha Lenz